PAVmed (PAVM) Share-based Compensation Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -29.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.98% |
| Sep 30, 2025 | -56.84% |
| Jun 30, 2025 | -68.14% |
| Mar 31, 2025 | -42.19% |
| Dec 31, 2024 | -44.89% |
| Jun 30, 2024 | -28.47% |
| Mar 31, 2024 | 9.43% |
| Dec 31, 2023 | 49.75% |
| Sep 30, 2023 | 56.47% |
| Jun 30, 2023 | 67.97% |
| Mar 31, 2023 | 134.20% |
| Dec 31, 2022 | 132.46% |
| Sep 30, 2022 | 143.49% |
| Jun 30, 2022 | 134.56% |
| Mar 31, 2022 | 118.89% |
| Dec 31, 2021 | 136.99% |
| Sep 30, 2021 | 130.82% |
| Jun 30, 2021 | 157.74% |
| Mar 31, 2021 | 74.28% |
| Dec 31, 2020 | 33.04% |
| Sep 30, 2020 | 29.11% |
| Jun 30, 2020 | 27.65% |
| Mar 31, 2020 | 8.05% |
| Dec 31, 2019 | 16.73% |
| Sep 30, 2019 | 0.72% |